Purpose: To investigate the
occurrence, species prevalence, antibacterial
resistance, and molecular characteristics of S. aureus
isolates from different wards located in a university
hospital.
Methods: A total of one hundred and
fifty S. aureus isolates were recovered from various
clinical specimens. The isolates were tested
phenotypically by conventional methods and genotypically
by polymease chain reaction (PCR) for direct detection
of femB and mecA genes.
Results: Thirty one isolates (20.7
%) of these were identified as methicillin-resistant
Staphylococcus aureus (MRSA) by oxacillin agar screen
test and 124 (82.7 %) of the isolates were β-lactamase
producers. The prevalence of MRSA strains among S.
aureus isolates was 20.7 %. The overall resistance of
MRSA to a variety of antibiotics tested was linezolid,
48.7 %; ciprofloxacin, 15.3 %; sulfa-methoxazole/trimethoprim
(TMS), 14.0 %; gentamicin, 12.7 %; and rifampicin, 6.7
%. All MRSA isolates were positive for femB and mecA
genes; one MSSA carried mecA gene.
Conclusion: Since S. aureus isolates
are commonly associated with wound infections, skin and
soft tissue infections and blood stream infections,
glycopeptides, mupirocin, and quinupristin/dalfopristin
(Q/D) would be the most effective antibiotics for the
treatment of MRSA infections.
Keywords: Staphylococcus aureus, mecA,
femB, Antibiotics, Staphylococcal infections,
Methicillin resistance